Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Makri, Olga E, Tsapardoni, Foteini N, Plotas, Panagiotis, Pallikari, Athina, Georgakopoulos, Constantine D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149836/
https://www.ncbi.nlm.nih.gov/pubmed/30271222
http://dx.doi.org/10.2147/IMCRJ.S166473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149836/
https://www.ncbi.nlm.nih.gov/pubmed/30271222
http://dx.doi.org/10.2147/IMCRJ.S166473

Ejemplares similares